Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-06 4:15 pm Sale | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Perceptive Advisors LLC | 0 0.000% | -2,099,952 (Position Closed) | Filing History |
| 2024-03-01 8:05 pm Sale | 2023-05-24 | 13D | Crinetics Pharmaceuticals, Inc. CRNX | Perceptive Advisors LLC | 1,488,703 1.900% | -3,844,829 (-72.09%) | Filing History |
| 2024-03-01 7:09 pm Purchase | 2024-02-20 | 13G | Iovance Biotherapeutics, Inc. IOVA | Perceptive Advisors LLC | 19,221,743 6.900% | 7,242,328 (+60.46%) | Filing History |
| 2024-02-29 7:45 pm Purchase | 2024-02-29 | 13D | LianBio LIANY | Perceptive Advisors LLC | 57,850,841 53.400% | 1,530,881 (+2.72%) | Filing History |
| 2024-02-23 4:16 pm Unchanged | 2024-02-23 | 13G | enVVeno Medical Corporation NVNO | Perceptive Advisors LLC | 1,394,716 9.900% | 0 (Unchanged) | Filing History |
| 2024-02-14 5:14 pm Sale | 2023-12-31 | 13G | Rain Enhancement Technologies Holdco Inc RAIN | Perceptive Advisors LLC | 0 0.000% | -2,483,619 (Position Closed) | Filing History |
| 2024-02-14 4:56 pm Purchase | 2023-12-31 | 13G | Forte Biosciences, Inc. FBRX | Perceptive Advisors LLC | 145,345 9.900% | 234 (+0.16%) | Filing History |
| 2024-02-14 4:52 pm Unchanged | 2023-12-31 | 13G | Applied Therapeutics, Inc. APLT | Perceptive Advisors LLC | 4,580,249 5.900% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:52 pm Unchanged | 2023-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX | Perceptive Advisors LLC | 8,593,586 14.600% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | Perceptive Advisors LLC | 4,776,306 9.900% | 1,462,523 (+44.13%) | Filing History |
| 2024-02-14 4:50 pm Sale | 2023-12-31 | 13G | Bellerophon Therapeutics, Inc. BLPH | Perceptive Advisors LLC | 0 0.000% | -930,000 (Position Closed) | Filing History |
| 2024-02-14 4:49 pm Sale | 2023-12-31 | 13G | ADMA Biologics, Inc. ADMA | Perceptive Advisors LLC | 6,433,369 2.800% | -5,466,886 (-45.94%) | Filing History |
| 2024-02-14 4:49 pm Unchanged | 2023-12-31 | 13G | Orchestra BioMed Holdings, Inc. OBIO | Perceptive Advisors LLC | 2,432,089 6.800% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:48 pm Purchase | 2023-12-31 | 13G | Arcellx, Inc. ACLX | Perceptive Advisors LLC | 4,544,809 8.800% | 1,946,504 (+74.91%) | Filing History |
| 2024-02-14 4:47 pm Purchase | 2023-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 709,918 16.900% | 206,020 (+40.89%) | Filing History |
| 2024-02-14 4:46 pm Sale | 2023-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | Perceptive Advisors LLC | 4,024,400 3.500% | -1,254,562 (-23.77%) | Filing History |
| 2024-02-14 4:46 pm Sale | 2023-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | Perceptive Advisors LLC | 0 0.000% | -2,860,000 (Position Closed) | Filing History |
| 2024-02-14 4:44 pm Sale | 2023-12-31 | 13G | Zymeworks Inc. ZYME | Perceptive Advisors LLC | 1,074,807 1.500% | -3,436,468 (-76.18%) | Filing History |
| 2024-02-14 4:41 pm Purchase | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Perceptive Advisors LLC | 267,494 6.200% | 42,624 (+18.96%) | Filing History |
| 2024-02-14 4:41 pm Purchase | 2023-12-31 | 13G | CARGO Therapeutics, Inc. Common Stock CRGX | Perceptive Advisors LLC | 3,436,600 8.300% | 190,432 (+5.87%) | Filing History |